Customers enter a Taco Bell restaurant on July 14, 2026 in La Cañada Flintridge, California. Mario Tama | Getty Images Taco Bell has removed lettuce linked to a cyclosporiasis outbreak from restaurants, it said Friday. The outbreak has currently affected more than 1,600 people across five states, according to the Centers for Disease Control and…
Smoke from massive wildfires in Canada engulf the New York City skyline, reducing visibility and casting an orange haze over the city, July 16, 2026. Selcuk Acar | Anadolu | Getty Images President Donald Trump on Friday blasted Canada for wildfires enveloping swaths of the United States in a smoky haze, and said he would…
Jaen city and surrounding Olive groves and trees, Jaen is known as the Olive Oil capital producing around 25% of global supply and over half of Spain’s olive oil production. Ucg | Universal Images Group | Getty Images Spain’s Deoleo, the world’s largest olive oil company, says a period of unprecedented volatility has unequivocally given…
UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company better manages high medical costs and uses AI to help streamline operations. The largest private insurer in the U.S. said it expects 2026 adjusted earnings of $19.50 to $20 per share, up from a previous…
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only half the battle. Keeping it off long term has proved even harder. Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around obesity treatment drive troves of patients – some studies estimate roughly half…
AstraZeneca‘s failed late-stage trial for Wainua was never expected to have a major financial impact on the company. Most analysts estimate the trial miss wiped just 2-4% from their valuation models. Yet the shares lost roughly twice that in a single session, suggesting the market reaction reflected more than just the loss of one drug,…
Abivax‘s latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without backing from Big Pharma, CEO Marc de Garidel told CNBC after months of intense takeover speculation. “Thanks to the cash we raised… We are in a position to have cash until the end of 2029, and…
Shares of AstraZeneca fell as much as 9% after a late stage clinical trial for an experimental heart disease failed to meet its target. The medicine, Wainua, did not reach its main goal of reducing deaths and recurrent heart-related emergencies over 140 weeks compared to a placebo, the British drugmaker said in a press release…
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. As new GLP-1 drugs enter the U.S. market and landmark Medicare coverage rolls out, one thing remains the same: Most employers still aren’t covering those drugs for…
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It’s a watershed move that could unlock a vast new patient population for Novo Nordisk and…
